General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
1 |
05/06/24 |
05/06/24 |
General
|
10K
|
3.8M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
1.0K
|
285K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
M@g123
|
126 |
29K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
126
|
29K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
M@g123
|
234 |
60K |
6 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
60K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.0K
|
285K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
21K |
7.2M |
16 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
21K
|
7.2M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
M@g123
|
64 |
19K |
18 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
64
|
19K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification regarding unquoted securities - RAC
|
|
M@g123
|
7 |
2.4K |
15 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
2.4K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Professor Erin Howden Joins Race Oncology SAB
|
|
M@g123
|
22 |
9.8K |
11 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
22
|
9.8K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
89 |
34K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
89
|
34K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
89 |
34K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
89
|
34K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
89 |
34K |
12 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
89
|
34K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
21K |
7.2M |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
21K
|
7.2M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
M@g123
|
89 |
34K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
89
|
34K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
5 |
01/03/24 |
01/03/24 |
General
|
10K
|
3.8M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
M@g123
|
54 |
13K |
15 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
54
|
13K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
21K |
7.2M |
7 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
21K
|
7.2M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
4 |
19/02/24 |
19/02/24 |
General
|
10K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
4 |
19/02/24 |
19/02/24 |
General
|
10K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
8 |
22/01/24 |
22/01/24 |
General
|
10K
|
3.8M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
M@g123
|
573 |
168K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
573
|
168K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
M@g123
|
573 |
168K |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
573
|
168K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: December 2023 Preclinical & Clinical Program Update
|
|
M@g123
|
66 |
21K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
21K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
M@g123
|
2.9K |
1.0M |
18 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
2.9K
|
1.0M
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
19 |
18/12/23 |
18/12/23 |
General
|
10K
|
3.8M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
M@g123
|
113 |
26K |
25 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
113
|
26K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML data presented at ASH conference
|
|
M@g123
|
53 |
15K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.0K
|
285K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.0K
|
285K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
3 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.0K
|
285K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
M@g123
|
1.0K |
285K |
2 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
1.0K
|
285K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
124K |
6 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
124K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
124K |
3 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
124K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
124K |
11 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
508
|
124K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
6 |
01/12/23 |
01/12/23 |
General
|
10K
|
3.8M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
M@g123
|
508 |
124K |
22 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
508
|
124K
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
8 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.8M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
4 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
22 |
30/11/23 |
30/11/23 |
General
|
10K
|
3.8M
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
M@g123
|
10K |
3.8M |
6 |
25/11/23 |
25/11/23 |
General
|
10K
|
3.8M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
M@g123
|
226 |
54K |
16 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
54K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
M@g123
|
226 |
54K |
20 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
54K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
M@g123
|
1.7K |
593K |
12 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
1.7K
|
593K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
M@g123
|
137 |
61K |
5 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
61K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
M@g123
|
231 |
66K |
10 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
231
|
66K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
M@g123
|
227 |
84K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
227
|
84K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
M@g123
|
231 |
66K |
20 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
66K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
M@g123
|
101 |
21K |
11 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
21K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
M@g123
|
101 |
21K |
10 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
21K
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
M@g123
|
21K |
7.2M |
17 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
21K
|
7.2M
|
17
|
|